Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Ability of Lactobacillus Crispatus CRP21 to Reduce the Incidence of Recurrent Bacterial Vaginosis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

NCT07474831 is registered in ClinicalTrials.gov with Liaquat University of Medical & Health Sciences as lead sponsor.

NCT NCT07474831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07474831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Ability of Lactobacillus Crispatus CRP21 to Reduce the Incidence of Recurrent Bacterial Vaginosis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Lead sponsor
Liaquat University of Medical & Health Sciences
Phase
Not applicable
Overall status
Recruiting
Start date
March 23, 2026
Completion date
April 16, 2027
Enrollment
132 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent bacterial vaginosis